<html>
<head>PUBMED IDs for FXYD2</head>
<body bgcolor='#C5F0F2'><h1>FXYD2</h1><a href='https://pubmed.ncbi.nlm.nih.gov/11062458/'>Dominant isolated renal magnesium loss is caused by misrouting of the Na(+),K(+)-ATPase gamma-subunit.</a> November 4  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/11062452/'>Of giant axons and curly hair.</a> November 4  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/11112438/'>Genomic organization of the human FXYD2 gene encoding the gamma subunit of the Na,K-ATPase.</a> December 9  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/11836293/'>Genetic heterogeneity in familial renal magnesium wasting.</a> February 12  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12584272/'>Exclusion of mutations in FXYD2, CLDN16 and SLC12A3 in two families with primary renal Mg2+ loss.</a> February 14  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12763862/'>Dominant isolated renal magnesium loss is caused by misrouting of the Na+,K+-ATPase gamma-subunit.</a> May 24  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14694143/'>Isoform specificity of human Na(+), K(+)-ATPase localization and aldosterone regulation in mouse kidney cells.</a> December 25  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/17050615/'>Multiplicity of expression of FXYD proteins in mammalian cells: dynamic exchange of phospholemman and gamma-subunit in response to stress.</a> October 20  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17980699/'>Impaired routing of wild type FXYD2 after oligomerisation with FXYD2-G41R might explain the dominant nature of renal hypomagnesemia.</a> November 6  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17980692/'>A reporter assay for Stat5-dependent promoters without cytokine stimulation.</a> November 6  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/19389850/'>HNF1B mutations associate with hypomagnesemia and renal magnesium wasting.</a> May 21  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19865785/'>FXYD2 and Na,K-ATPase expression in isolated human proximal tubular cells: disturbed upregulation on renal hypomagnesemia?</a> March 27  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19879113/'>Differential cellular expression of FXYD1 (phospholemman) and FXYD2 (gamma subunit of Na, K-ATPase) in normal human tissues: a study using high density human tissue microarrays.</a> May 1  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19879111/'>Association of promoter variants of human dopamine transporter gene with schizophrenia in Han Chinese.</a> February 25  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/21130072/'>HNF-1B specifically regulates the transcription of the Î³a-subunit of the Na+/K+-ATPase.</a> February 15  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/23636770/'>Tissue-specific expression and in vivo regulation of zebrafish orthologues of mammalian genes related to symptomatic hypomagnesemia.</a> April 4  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24204001/'>Mutations in PCBD1 cause hypomagnesemia and renal magnesium wasting.</a> May 9  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24258619/'>FXYD2c plays a potential role in modulating Na(+)/K (+)-ATPase activity in HK-2 cells upon hypertonic challenge.</a> August 15  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/25765846/'>Recurrent FXYD2 p.Gly41Arg mutation in patients with isolated dominant hypomagnesaemia.</a> October 21  2015<br></body></html>
